Viewing nowCombinationPosiCombi Tablet 10/100 Milligrams
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.

MFDS item code 202200499 · Approved 2022.01.28 · Insurance code 649405640
Improvement in blood sugar control for type 2 diabetes
This medication is prescribed to assist in blood sugar control for patients with type 2 diabetes using a combination of sitagliptin and dapagliflozin. It is effective when used alongside dietary and exercise regimens to support effective blood sugar management. This helps stabilize blood sugar levels and improve diabetes symptoms.
This medication can be administered as 1 tablet once daily without regard to meals for patients taking sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.
This medication contains two components that help in blood sugar control and is used for the treatment of diabetes. While taking this medication, allergic reactions may occur, so if symptoms such as rash, itching, or difficulty breathing arise, stop taking it immediately and consult a doctor. There is a risk of developing a serious inflammation of the pancreas called pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting arise, inform a healthcare provider immediately. This medication is not recommended for patients with certain genetic disorders, type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Patients with reduced kidney function or the elderly require dosage adjustments and periodic kidney function tests, and should be cautious of the risk of fluid depletion and hypotension. During treatment, the risk of genital and urinary infections may increase, so appropriate treatment should be sought for any infection symptoms. Hypoglycemic symptoms may occur, so blood sugar levels should be monitored carefully, especially when taken with other hypoglycemic agents such as insulin or sulfonylureas. It is advised that pregnant or breastfeeding women do not use this medication, and it should be discontinued immediately if pregnancy is confirmed. The elderly are at higher risk of decreased kidney function, so regular kidney function tests are necessary, and dosage adjustments should be made with caution. In case of overdose, there is no specific antidote, so treatment should be symptomatic and in accordance with healthcare provider instructions. There is generally no significant effect of this medication when taken alone on driving or operating machinery, but caution is necessary due to the risk of hypoglycemia when used with other hypoglycemic agents. The safety and efficacy of this medication have not been established in children, so it is not recommended for individuals under 18 years of age. Store the medication in its original container and keep it out of reach of children.
Hypoglycemia, dizziness, constipation, dry mouth, back pain, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine, elevated blood urea, weight loss, upper respiratory infection, nasopharyngitis, headache, diarrhea, nausea, abdominal pain, vomiting, dyspepsia, vertigo, palpitations, insomnia, tinnitus, menstrual irregularities, vaginal discharge, itching
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.
Yellow, rectangular film-coated tablets
28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.